|

Human CD19Targeted T Cells Injection Clinical Trials

1 actively recruiting trial

Also known as: CD19 CAR-T

Pipeline

Phase 2: 1

Top Sponsors

  • Hrain Biotechnology Co., Ltd.1

Indications

  • B-cell Non-Hodgkin's Lymphoma1
  • Cancer1

Other1 trial

Human CD19 Targeted T Cells Injection(CD19 CAR-T) Therapy for Relapsed and Refractory B-cell Non-Hodgkin's Lymphoma
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.